| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/08/2001 | CA2384194A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2383877A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | CA2383784A1 Apoptin-associating protein |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383606A1 Iren protein, its preparation and use |
| 03/08/2001 | CA2383603A1 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | CA2383519A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 03/08/2001 | CA2383517A1 Radiopharmaceutical products and their preparation procedure |
| 03/08/2001 | CA2383514A1 Screening for agents modulating tgf-beta cell signaling |
| 03/08/2001 | CA2383381A1 Methods and compositions relating to body weight and eating disorders |
| 03/08/2001 | CA2383347A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | CA2383077A1 Androgen receptor modulator compounds and methods |
| 03/08/2001 | CA2383043A1 Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders |
| 03/08/2001 | CA2382835A1 Use of amino acids for making medicines for treating to insulin-resistance |
| 03/08/2001 | CA2382789A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | CA2382622A1 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | CA2382449A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | CA2382427A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | CA2382345A1 Extended duration light activated cancer therapy |
| 03/08/2001 | CA2382303A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | CA2382100A1 Dosages for treatment with anti-erbb2 antibodies |
| 03/08/2001 | CA2382034A1 Medicaments that contain xenogenic oligo- or/and polyribonucleotides |
| 03/08/2001 | CA2381821A1 Substituted indolinones, their manufacture and their use as medicaments |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | CA2379421A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 03/08/2001 | CA2378298A1 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators |
| 03/08/2001 | CA2348565A1 Methods and compositions for selective cancer chemotherapy |
| 03/08/2001 | CA2348158A1 Modified adenoviral fibre and uses thereof |
| 03/07/2001 | EP1081226A1 Apoptin-associating protein |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1080726A1 Agents for relieving side effects |
| 03/07/2001 | EP1080370A1 Identification of broadly reactive dr restricted epitopes |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080190A1 Calmodulin related protein |
| 03/07/2001 | EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway |
| 03/07/2001 | EP1080184A1 Method for activating natural killer (nk) cells |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080113A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080103A1 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 03/07/2001 | EP1080100A1 Cytosine deaminase gene |
| 03/07/2001 | EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/07/2001 | EP1080092A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 03/07/2001 | EP1080090A1 Antitumour 1,5-diazaanthraquinones |
| 03/07/2001 | EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 03/07/2001 | EP1080079A1 Thermally stable trimetrexates and processes for producing the same |
| 03/07/2001 | EP1080074A1 New heterocyclically substituted amides, their production and their use |
| 03/07/2001 | EP1080070A2 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1080066A1 Bioreductive cytotoxic agents |
| 03/07/2001 | EP1080057A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
| 03/07/2001 | EP1080055A2 24-hydroxyvitamin d, analogs and uses thereof |
| 03/07/2001 | EP1079875A2 Method and compositions for treatment of cancers |
| 03/07/2001 | EP1079864A1 Materials and methods for delivery and expression of heterologous dna in vertebrate cells |
| 03/07/2001 | EP1079862A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 03/07/2001 | EP1079858A2 Oral immunization with papillomavirus virus-like particles |
| 03/07/2001 | EP1079851A1 Use of anti-prolactin agents to treat proliferative conditions |
| 03/07/2001 | EP1079849A2 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079842A1 Use of crataegus formulations for prophylaxis and treatment of neoplastic diseases |
| 03/07/2001 | EP1079838A1 Edelfosin for the treatment of brain tumours |
| 03/07/2001 | EP1079837A1 Method of inhibiting membrane-type matrix metalloproteinase |
| 03/07/2001 | EP1079832A1 Use of vitamin pp compounds |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079824A1 Triterpene compositions and methods for use thereof |
| 03/07/2001 | EP1079818A1 Novel compositions |
| 03/07/2001 | EP1079792A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases |
| 03/07/2001 | EP0918874B1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 03/07/2001 | EP0783505B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 03/07/2001 | EP0730597B1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 03/07/2001 | EP0620736B1 Use of leukemia inhibiting factor (lif) for the treatment of tumours and sarcomas |
| 03/07/2001 | EP0486526B2 Tumour necrosis factor binding ligands |
| 03/07/2001 | CN1286690A Compounds useful for inhibition of farnesyl protein transferase |
| 03/07/2001 | CN1286685A Heterocyclic cytotoxic agents |
| 03/07/2001 | CN1286681A Cytostatic agents |
| 03/07/2001 | CN1286630A Targeted liposome gene delivery |
| 03/07/2001 | CN1286258A Purine L-nucleoside, analogs and use thereof |
| 03/07/2001 | CN1286122A Radioactive Re labelled glucosan medicines and preparing process thereof |
| 03/07/2001 | CN1286119A Health-care lucid qanoderma product and its preparing process |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062858C Phenyl-substd alkenylcarboguanidides carrying perfluoroalkyl groups, process for their preparation, their use as medicament and medicines |
| 03/07/2001 | CN1062764C Anticancer medicine and producing method thereof |
| 03/07/2001 | CN1062763C Medicine for treating gastric cancer and preparation method thereof |
| 03/06/2001 | US6197982 Vitamin D analogues |
| 03/06/2001 | US6197980 4-Acetoxy-2α-benzoyloxy-5β,20-epoxy-1β,7β,10β-trihydroxy-9-oxo-11-taxen-13α-yl(2R,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate trihydrate |
| 03/06/2001 | US6197975 7-azabicyclo(2.2.1)heptane-7-carbonyl-substituted 2-phenylindole derivatives; sexual disorders; anticarcinogenic agents |
| 03/06/2001 | US6197955 Production of staurosporine derivative using acid isomerization |
| 03/06/2001 | US6197939 Polypeptide regulator; for use as a diagnostic tool in detection of tumors |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197809 Doxorubicin antibiotic |
| 03/06/2001 | US6197797 Cyanoguanidines as cell proliferation inhibitors |
| 03/06/2001 | US6197786 Anticholesterol agents |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/06/2001 | US6197760 Isophosphoramide mustard analogs and use thereof |
| 03/06/2001 | US6197757 Particles, especially microparticles or nanoparticles, of crosslinked monosaccharides and oligosaccharides, processes for their preparation and cosmetic, pharmaceutical or food compositions in which they are present |
| 03/06/2001 | US6197755 Compositions and methods for delivery of genetic material |
| 03/06/2001 | US6197754 Tyrosine kinase inhibitor |